Duke University Medical Center

Oncology & Cancer

Biomarker predicts resistance to immunotherapies in melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...

HIV & AIDS

Study identifies how stealthy HIV evades drugs and immunity

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health ...

Oncology & Cancer

Cancer repair mechanism could be potential drug target

While cancer therapies targeting specific genes or disease pathways can extend lives, they can also lead to highly resistant tumors when small reservoirs of cancer cells survive treatment, grow, and spread.

page 3 from 40